
Legal Aspects of FDA approval and implications for clinical research
04/20/22 • 23 min
We would love to hear your thoughts on the episodes!
Prof. Christine Coughlin of Wake Forest School of Law speaks with Dr. Thomas Nero on the FDA approval process, emergency use authorization, Right to Try Legislation and the implications for clinical research, diversity and health care equity. Prof. Coughlin holds positions in the College of Medicine as well as the Law school and in the Center for Bioethics. She has published extensively on the FDA approval process.
We would love to hear your thoughts on the episodes!
Prof. Christine Coughlin of Wake Forest School of Law speaks with Dr. Thomas Nero on the FDA approval process, emergency use authorization, Right to Try Legislation and the implications for clinical research, diversity and health care equity. Prof. Coughlin holds positions in the College of Medicine as well as the Law school and in the Center for Bioethics. She has published extensively on the FDA approval process.
Previous Episode

Coronary Artery Disease in the Athlete with Dr Paul Thompson
We would love to hear your thoughts on the episodes!
Although exercise usually provides a cardiovascular benefit, there is some data that points to an increase in event rates in extreme endurance athletes. In this episode, Dr. Thomas Nero and Dr. Paul Thompson discuss the surprising findings regarding coronary calcium, cardiac troponins and atrial fibrillation in the endurance athlete and some thoughts about ideas to pursue in future research.
Next Episode

Evaluation of Coronary Inflammation with CT angiography and Fat Attenuation Indexing
We would love to hear your thoughts on the episodes!
Dr. Nero discusses evaluation of coronary artery disease and coronary inflammaiton with Dr. Cheerag Shirodaria from the University of Oxford. Dr. Shirodaria along with Prof. Charalambos Antonidies at Caristo Diagnostics have developed a ground breaking technology that allows us to evaluate not just the severity of a coronary artery lesion, but also how inflamed it is and how likely it is to cause fatal and non-fatal myocardial infarction. In addition, since it is a biologically active "marker" the Fat Attenuation Index (FAI) can also be used a a way to evaluate success of medical intervention. Using computer post processing from standard 64 or 128 slice CT coronary angiography, they have been able to evaluate not just the vulnerable patient but also (possibly) the vulnerable plaque.
Future Pulse Cardiology - Legal Aspects of FDA approval and implications for clinical research
Transcript
Legal Aspects of FDA Approval Process and Implications for Clinical Research
[00:00:00] Dr. Thomas Nero: Hello I'm Dr Thomas Nero And today we're going to be taking a shift from our normal podcast to talking a little bit about healthcare policy joining us today is professor Christine Coughlin professor Coughlin is a professor of law at wake forest university school of law . She has an appointment in the graduate school of arts and sciences and also the center of bioethic
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/future-pulse-cardiology-277889/legal-aspects-of-fda-approval-and-implications-for-clinical-research-34302561"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to legal aspects of fda approval and implications for clinical research on goodpods" style="width: 225px" /> </a>
Copy